These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8066765)

  • 21. [Lung rejection in pulmonary and cardiopulmonary transplantation].
    Groussard O
    Ann Pathol; 1993; 13(1):8-16. PubMed ID: 8489655
    [No Abstract]   [Full Text] [Related]  

  • 22. Paneth and goblet cells modify their sugar moieties during acute rejection and up to one year after small bowel transplantation in rats.
    Michalski S; Quondamatteo F; Meyer E; Schlemminger R; Herken R; Becker HD
    Transplant Proc; 1996 Oct; 28(5):2477-8. PubMed ID: 8907911
    [No Abstract]   [Full Text] [Related]  

  • 23. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study.
    Alessiani M; De Ponti F; Fayer F; Abbiati F; Zonta S; Zitelli E; Arbustini E; Morbini P; Poggi N; Klersy C; Blangetti I; Dionigi P; Zonta A
    Transpl Int; 2003 May; 16(5):327-35. PubMed ID: 12759724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of time of rejection on long-term graft survival in renal transplantation.
    Opelz G; Döhler B;
    Transplantation; 2008 Mar; 85(5):661-6. PubMed ID: 18337655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
    Takeshita K; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Kobayashi K; Imanishi J; Oka T
    Transplant Proc; 1996 Apr; 28(2):631-2. PubMed ID: 8623314
    [No Abstract]   [Full Text] [Related]  

  • 28. Behavior of serum cytokine levels and peripheral lymphocyte subsets after H-LTx.
    Ippoliti G
    Transplant Proc; 1995 Jun; 27(3):2021-2. PubMed ID: 7792873
    [No Abstract]   [Full Text] [Related]  

  • 29. Pravastatin prolongs graft survival in an allogeneic rat model of orthotopic single lung transplantation.
    Li Y; Köster T; Mörike C; v Hörsten S; Martin U; Bader M; Haverich A; Simon AR
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):515-24. PubMed ID: 16860567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal human polyclonal immunoglobulins delay xenograft rejection through distinct F(ab')2 and Fc mediated mechanisms.
    Genevaz D; Latremouille C; Goussev N; Carpentier A; Glotz D
    Transplant Proc; 1996 Apr; 28(2):853-4. PubMed ID: 8623433
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.
    Pfeiffer S; Zorn GL; Zhang JP; Giorgio TD; Robson SC; Azimzadeh AM; Pierson RN
    Transplantation; 2003 Apr; 75(7):953-9. PubMed ID: 12698079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical heart transplantation. Total lymphoid irradiation for resistant rejection after heart transplantation: only moderate success medium-term.
    Keogh A; Morgan G; Macdonald P; Spratt P; Mundy J; McCosker C
    J Heart Lung Transplant; 1996 Mar; 15(3):231-3. PubMed ID: 8777203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rejection and accommodation in the hamster-to-rat heart transplantation model.
    Bouwman E; Scheringa M; Nio D; IJzermans JN; Marquet RL
    Transplant Proc; 1994 Apr; 26(2):992-3. PubMed ID: 8171723
    [No Abstract]   [Full Text] [Related]  

  • 34. Thoracic transplantation in the United States: an analysis of UNOS Registry data.
    Cai J
    Clin Transpl; 2006; ():41-56. PubMed ID: 18365368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
    Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
    Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
    [No Abstract]   [Full Text] [Related]  

  • 36. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesion molecules in rejection and tolerance of allografts.
    Hourmant M; Dantal J
    Nephrol Dial Transplant; 1996 Aug; 11(8):1661-6. PubMed ID: 8856234
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA.
    Halloran PF; Hunsicker LG
    Am J Transplant; 2001 Jul; 1(2):115-20. PubMed ID: 12099358
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical lung xenotransplantation--what donor genetic modifications may be necessary?
    Cooper DK; Ekser B; Burlak C; Ezzelarab M; Hara H; Paris L; Tector AJ; Phelps C; Azimzadeh AM; Ayares D; Robson SC; Pierson RN
    Xenotransplantation; 2012; 19(3):144-58. PubMed ID: 22702466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms governing the pace and character of pig heart-lung rejection by human blood.
    Pierson RN; Dunning JJ; Konig WK; Tew DN; Braidley PC; Wallwork J; White DJ
    Transplant Proc; 1994 Aug; 26(4):2337. PubMed ID: 8066765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.